| A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 … I Pinal-Fernandez, M Casal-Dominguez, JA Huapaya, J Albayda, JJ Paik, ... Rheumatology 56 (6), 999-1007, 2017 | 211 | 2017 |
| Antinuclear matrix protein 2 autoantibodies and edema, muscle disease, and malignancy risk in dermatomyositis patients J Albayda, I Pinal‐Fernandez, W Huang, C Parks, J Paik, ... Arthritis care & research 69 (11), 1771-1776, 2017 | 138 | 2017 |
| Assessment of mortality in autoimmune myositis with and without associated interstitial lung disease C Johnson, I Pinal-Fernandez, R Parikh, J Paik, J Albayda, AL Mammen, ... Lung 194, 733-737, 2016 | 126 | 2016 |
| Management of myositis-related interstitial lung disease J Morisset, C Johnson, E Rich, HR Collard, JS Lee Chest 150 (5), 1118-1128, 2016 | 122 | 2016 |
| Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodies R De Lorenzo, I Pinal-Fernandez, W Huang, J Albayda, E Tiniakou, ... Neurology 90 (23), e2068-e2076, 2018 | 92 | 2018 |
| Long-term treatment with azathioprine and mycophenolate mofetil for myositis-related interstitial lung disease JA Huapaya, L Silhan, I Pinal-Fernandez, M Casal-Dominguez, ... Chest 156 (5), 896-906, 2019 | 88 | 2019 |
| Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease JT Giles, E Darrah, S Danoff, C Johnson, F Andrade, A Rosen, JM Bathon PloS one 9 (6), e98794, 2014 | 74 | 2014 |
| Recent advances in the pathogenesis, prediction, and management of rheumatoid arthritis-associated interstitial lung disease C Johnson Current Opinion in Rheumatology 29 (3), 254-259, 2017 | 63 | 2017 |
| Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type C Johnson, GR Connors, J Oaks, S Han, A Truong, B Richardson, ... Respiratory medicine 108 (10), 1542-1548, 2014 | 59 | 2014 |
| Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies M Casal-Dominguez, I Pinal-Fernandez, AM Corse, J Paik, J Albayda, ... Neurology 92 (13), e1416-e1426, 2019 | 46 | 2019 |
| “Hiker’s feet”: a novel cutaneous finding in the inflammatory myopathies JT Cox, DM Gullotti, CA Mecoli, AH Lahouti, J Albayda, J Paik, C Johnson, ... Clinical rheumatology 36, 1683-1686, 2017 | 46 | 2017 |
| More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodies I Pinal-Fernandez, CA Mecoli, M Casal-Dominguez, K Pak, Y Hosono, ... Neurology 93 (19), e1768-e1777, 2019 | 38 | 2019 |
| Autoantibody seropositivity and risk for interstitial lung disease in a prospective male-predominant rheumatoid arthritis cohort of US veterans JG Natalini, JF Baker, N Singh, TD Mahajan, P Roul, GM Thiele, ... Annals of the American Thoracic Society 18 (4), 598-605, 2021 | 35 | 2021 |
| Long-term treatment with human immunoglobulin for antisynthetase syndrome-associated interstitial lung disease JA Huapaya, R Hallowell, L Silhan, I Pinal-Fernandez, ... Respiratory Medicine 154, 6-11, 2019 | 31 | 2019 |
| Dermatomyositis patients with anti-nuclear matrix protein-2 autoantibodies have more edema, more severe muscle disease, and increased malignancy risk J Albayda, I Pinal-Fernandez, W Huang, C Parks, J Paik, ... Arthritis care & research 69 (11), 1771, 2017 | 28 | 2017 |
| Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis C Johnson, P Rosen, T Lloyd, M Horton, L Christopher-Stine, CV Oddis, ... Respiratory Medicine 130, 52-54, 2017 | 25 | 2017 |
| Smoking and subclinical ILD in RA versus the multi-ethnic study of atherosclerosis C Johnson, JT Giles, J Bathon, D Lederer, EA Hoffman, RG Barr, ... PloS one 11 (4), e0153024, 2016 | 21 | 2016 |
| Efficacy and adverse effects of methotrexate compared with azathioprine in the antisynthetase syndrome M Casal-Dominguez, I Pinal-Fernandez, J Huapaya, J Albayda, JJ Paik, ... Clin Exp Rheumatol 37 (5), 858-861, 2019 | 18 | 2019 |
| The ILD-GAP risk prediction model performs poorly in myositis-associated interstitial lung disease RM Brusca, I Pinal-Fernandez, K Psoter, JJ Paik, J Albayda, C Mecoli, ... Respiratory medicine 150, 63-65, 2019 | 14 | 2019 |
| Assessing predictors of rheumatoid arthritis-associated interstitial lung disease using quantitative lung densitometry MK Alevizos, SK Danoff, DA Pappas, DJ Lederer, C Johnson, EA Hoffman, ... Rheumatology 61 (7), 2792-2804, 2022 | 12 | 2022 |
